Drug Safety Update - March 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for March 2023 (PDF).
This issue contains the latest COVID-19 vaccine and medicine information including the latest summary of Yellow Card reports that would include the Autumn 2022 booster campaign. Given the stable safety profile of these vaccines this will be the last special analysis of COVID-19 vaccines. In the future the established routine data publication and communication methods for reporting safety concerns will be used.
Lastly in this issue is a summary of letters to healthcare professionals in February. These generally related to supply issues and recalls.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « NICE Guidance - March 2023 | Prescription Charge Changes for 2023 » |
Leave a Comment